Rosas G, Cerdeyra C, Lucas M A, Parano J R, Villa J J
Angiology. 1981 May;32(5):291-7. doi: 10.1177/000331978103200501.
In a group of 58 patients with peripheral arteriopathies, we have studied efficacy and safety of buflomedil hydrochloride and naftidrofuryl. Both drugs have been shown to have vasoactive properties evaluated through walking capacity and time of hyperemia. According to our results, buflomedil is more effective and safe than naftidrofuryl in the treatment of patients with intermittent claudication.
在一组58例外周动脉疾病患者中，我们研究了盐酸丁咯地尔和萘呋胺酯的疗效及安全性。通过步行能力和充血时间评估，这两种药物均已显示出血管活性特性。根据我们的结果，在治疗间歇性跛行患者方面，盐酸丁咯地尔比萘呋胺酯更有效且更安全。
